Quantifying Significance of MHC II Residues

被引:0
|
作者
Fan, Ying [1 ]
Lu, Ruoshui [1 ]
Wang, Lusheng [1 ]
Andreatta, Massimo [2 ]
Li, Shuai Cheng [1 ]
机构
[1] City Univ Hong Kong, Dept Comp Sci, Kowloon, Hong Kong, Peoples R China
[2] City Univ Hong Kong, Dept Math, Kowloon, Hong Kong, Peoples R China
关键词
MHC II molecules; quantify significant residues (positions); integer linear programming; BETA-CHAIN PLAYS; PEPTIDE-BINDING; CRYSTAL-STRUCTURE; PROTEIN HLA-DR1; ACID; SUSCEPTIBILITY; SUPERTYPES; EPITOPES; SARCOIDOSIS; MOLECULES;
D O I
10.1109/TCBB.2013.138
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The major histocompatibility complex (MHC), a cell-surface protein mediating immune recognition, plays important roles in the immune response system of all higher vertebrates. MHC molecules are highly polymorphic and they are grouped into serotypes according to the specificity of the response. It is a common belief that a protein sequence determines its three dimensional structure and function. Hence, the protein sequence determines the serotype. Residues play different levels of importance. In this paper, we quantify the residue significance with the available serotype information. Knowing the significance of the residues will deepen our understanding of the MHC molecules and yield us a concise representation of the molecules. In this paper we propose a linear programming-based approach to find significant residue positions as well as quantifying their significance in MHC II DR molecules. Among all the residues in MHC II DR molecules, 18 positions are of particular significance, which is consistent with the literature on MHC binding sites, and succinct pseudo-sequences appear to be adequate to capture the whole sequence features. When the result is used for classification of MHC molecules with serotype assigned by WHO, a 98.4 percent prediction performance is achieved. The methods have been implemented in java (http://code.google.com/p/quassi/).
引用
收藏
页码:17 / 25
页数:9
相关论文
共 50 条
  • [31] MHC class II trafficking
    Bell, E
    NATURE REVIEWS IMMUNOLOGY, 2002, 2 (09) : 628 - 628
  • [32] Expression of MHC II genes
    Drozina, G
    Kohoutek, J
    Jabrane-Ferrat, N
    Peterlin, BM
    MOLECULAR ANALYSIS OF B LYMPHOCYTE DEVELOPMENT AND ACTIVATION, 2005, 290 : 147 - 170
  • [33] MHC Class II Tetramers
    Nepom, Gerald T.
    JOURNAL OF IMMUNOLOGY, 2012, 188 (06): : 2477 - 2482
  • [34] Mutation of RFXAP, a regulator of MHC class II genes, in primary MHC class II deficiency
    Villard, J
    LisowskaGrospierre, B
    vandenElsen, P
    Fischer, A
    Reith, W
    Mach, B
    NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (11): : 748 - 753
  • [35] MIMICRY OF MHC ANTIGENS BY HIV - PATHOLOGICAL SIGNIFICANCE
    GRANT, M
    IMMUNOLOGY TODAY, 1992, 13 (12): : 512 - 513
  • [36] MHC class II-restricted antigen processing and presentation: a critical role for cysteine residues in epitope selection.
    Li, P
    Blum, JS
    FASEB JOURNAL, 2001, 15 (04): : A675 - A675
  • [37] Functional consequences of the binding of MHC class II-derived peptides to MHC class II
    FeiliHariri, M
    Kao, H
    Mietzner, TA
    Morel, PA
    INTERNATIONAL IMMUNOLOGY, 1996, 8 (12) : 1857 - 1865
  • [38] Structural Properties of MHC Class II Ligands, Implications for the Prediction of MHC Class II Epitopes
    Jorgensen, Kasper Winther
    Buus, Soren
    Nielsen, Morten
    PLOS ONE, 2010, 5 (12):
  • [39] REEXPRESSION OF MHC CLASS-II GENES IN MHC CLASS-II NEGATIVE CELLS
    CHANG, CH
    FLAVELL, RA
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 307 - 307
  • [40] Cohesin Regulates MHC Class II Genes through Interactions with MHC Class II Insulators
    Majumder, Parimal
    Boss, Jeremy M.
    JOURNAL OF IMMUNOLOGY, 2011, 187 (08): : 4236 - 4244